help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 10, 2008
Endocrinology, doi:10.1210/en.2007-1573
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/4/1960    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, S.
Right arrow Articles by Xiao, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, S.
Right arrow Articles by Xiao, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PARATHYROID HORMONE

Submitted on November 15, 2007
Accepted on December 31, 2007

Parathyroid Hormone Increases Activating Transcription Factor 4 Expression and Activity in Osteoblasts: Requirement for Osteocalcin Gene Expression

Shibing Yu, Renny T. Franceschi, Min Luo, Xiaoyan Zhang, Di Jiang, Yumei Lai, Yu Jiang, Jian Zhang, and Guozhi Xiao*

Department of Medicine, and Pharmacology, University of Pittsburgh, Pittsburgh, PA 15240, Department of Periodontics and Oral Medicine, School of Dentistry, and Biological Chemistry, School of Medicine, University of Michigan, Ann Arbor, MI 48109

* To whom correspondence should be addressed. E-mail: xiaog{at}upmc.edu.

Parathyroid hormone (PTH) is an important peptide hormone regulator of calcium homeostasis and osteoblast function. However, its mechanism of action in osteoblasts is poorly understood. Our previous study demonstrated that PTH activates mouse osteocalcin (Ocn) gene 2 (mOG2) promoter through the OSE1 site (Jiang et al., JBC 279, 5329–5337,2004), a recently identified ATF4-binding element. In the present study, we examine effects of PTH on ATF4 expression and activity as well as the requirement for ATF4 in the regulation of Ocn by PTH. Results show that PTH elevated levels of ATF4 mRNA and protein in a dose and time-dependent manner. This PTH regulation requires transcriptional activity, but not de novo protein synthesis. PTH also increased binding of nuclear extracts to OSE1 DNA. PTH stimulated ATF4-dependent transcriptional activity mainly through PKA with a lesser requirement for PKC and MAPK/ERK pathways. Lastly, PTH stimulation of Ocn expression was lost by siRNA down-regulation of ATF4 in MC-4 cells and in Atf4- bone marrow stromal cells (BMSCs). Collectively, these studies for the first time demonstrate that PTH increases ATF4 expression and activity and that ATF4 is required for PTH induction of Ocn expression in osteoblasts.


Key words: Parathyroid Hormone • Activating Transcription Factor 4 • Osteocalcin







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society